ABG Analytics logo
Get updates

Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 12/23/2022
Closing price: 111.86
Support price level: $100.61
Resistance price level: N/A
Relative strength index (14-day RSI) 57.2
Beta 0.37
  • MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • With a 47.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.

  • MRK is one of this month's top performers with a return of 4.1 percent, beating 90 percent of stocks in the S&P-100.

  • The price of this low-beta stock is expected to increase by 0.37% for every 1% increase in the S&P-500.

  • MRK is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 17.5%.

  • Volatility is forecast to fall over the next month.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$73.51 $111.86 100.0%
200 day 50 day 20 day 10 day
$92.01 $103.82 $109.98 $110.36
(Annualized standard deviation)
(5 year)
Last month Current estimate Next month forecast
22.4% 21.5% 17.5% 20.3%
There is an estimated 5% probability that the stock price of Merck & Co will fall by more than:
  • 4.8% in the next week.

  • 11.5% in the next month.

  • 43.3% in the next year.